Richard Dana Ono's most recent trade in Lipocine Inc was a trade of 1,764 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lipocine Inc | Richard Dana Ono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,764 | 10,938 | - | - | Common Stock (Right to Buy) | |
Lipocine Inc | Richard Dana Ono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 30,000 | 166,000 | - | - | Common Stock (Right to Buy) | |
Lipocine Inc | Richard Dana Ono | Director | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 20 Mar 2023 | 4,000 | 14,125 (0%) | 0% | 0.3 | 1,360 | Common Stock |
Lipocine Inc | Richard Dana Ono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 136,000 | - | - | Common Stock (Right to Buy) | |
Lipocine Inc | Richard Dana Ono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 22,000 | 22,000 | - | - | Common Stock (Right to Buy) | |
Lipocine Inc | Richard Dana Ono | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 5,250 | 10,125 (0%) | 0% | 0 | Common Stock | |
Lipocine Inc | Richard Dana Ono | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 5,250 | 5,250 | - | - | Restricted Stock Unit | |
Lipocine Inc | Richard Dana Ono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |